chr12-4518790-ACTTT-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_020374.4(C12orf4):c.815_818del(p.Glu272ValfsTer6) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000021 in 1,426,718 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
C12orf4
NM_020374.4 frameshift
NM_020374.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.80
Genes affected
C12orf4 (HGNC:1184): (FERRY endosomal RAB5 effector complex subunit 3) This gene is highly conserved from nematodes to humans. In rat, the orthologous gene encodes a cytoplasmic protein that is involved in mast cell degranulation. The human gene has been implicated in autosomal recessive intellectual disability. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-4518790-ACTTT-A is Pathogenic according to our data. Variant chr12-4518790-ACTTT-A is described in ClinVar as [Pathogenic]. Clinvar id is 2197319.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C12orf4 | NM_020374.4 | c.815_818del | p.Glu272ValfsTer6 | frameshift_variant | 7/14 | ENST00000261250.8 | NP_065107.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C12orf4 | ENST00000261250.8 | c.815_818del | p.Glu272ValfsTer6 | frameshift_variant | 7/14 | 1 | NM_020374.4 | ENSP00000261250 | P1 | |
C12orf4 | ENST00000545746.5 | c.815_818del | p.Glu272ValfsTer6 | frameshift_variant | 7/14 | 1 | ENSP00000439996 | P1 | ||
C12orf4 | ENST00000541014.5 | c.296_299del | p.Glu99ValfsTer6 | frameshift_variant | 6/8 | 5 | ENSP00000440820 | |||
C12orf4 | ENST00000544697.1 | c.210-539_210-536del | intron_variant, NMD_transcript_variant | 5 | ENSP00000439471 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000845 AC: 2AN: 236676Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 128086
GnomAD3 exomes
AF:
AC:
2
AN:
236676
Hom.:
AF XY:
AC XY:
0
AN XY:
128086
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000210 AC: 3AN: 1426718Hom.: 0 AF XY: 0.00000141 AC XY: 1AN XY: 709554
GnomAD4 exome
AF:
AC:
3
AN:
1426718
Hom.:
AF XY:
AC XY:
1
AN XY:
709554
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 27, 2022 | This sequence change creates a premature translational stop signal (p.Glu272Valfs*6) in the C12orf4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in C12orf4 are known to be pathogenic (PMID: 27311568). This variant is present in population databases (rs750549000, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with C12orf4-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -16
Find out detailed SpliceAI scores and Pangolin per-transcript scores at